The Lustgarten Foundation for Pancreatic Cancer Research Company Profile
Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit supporter of pancreatic cancer research, providing more than $20 million to date. The Foundation provides patient information and manages a national public awareness campaign. To learn more and to see Dr. Pausch's PSA, visit www.lustgarten.org.
News Articles
The Lustgarten Foundation Awards $25M to Accelerate the Rate of Pancreatic Cancer Research
The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced that it has awarded $25 million in new multi-year research grants. The research initiati...
The Lustgarten Foundation Presents Five Most Important Things To Know About Pancreatic Cancer
BETHPAGE, N.Y., Sept. 27, 2012 /PRNewswire/ -- The first anniversary of the death of Apple co-founder Steve Jobs on October 5 reminds us of the importance and need for research in the fight against pa...
BOSTON, Mass., April 9, 2013 /PRNewswire/ -- The Lustgarten Foundation and the Pancreatic Cancer Action Network are proud to announce that they will join forces and efforts for Unite to Fight Pan...
Lustgarten Foundation’s Pancreatic Research Lab Opens
NYU Dentistry and Medicine are awarded a $840,864 collaborative grant by the Lustgarten Foundation
(New York University) New York University College of Dentistry and New York University School of Medicine researchers have been awarded a four-year $840,864 collaborative grant by the Lustgarten Found...
BETHPAGE, N.Y., Dec. 7, 2012 /PRNewswire/ -- Cablevision Systems Corporation (NYSE: CVC), AMC Networks (NASDAQ: AMCX), and The Madison Square Garden Company (NASDAQ: MSG) presented the twelfth an...
The Lustgarten Foundation Awards $25 Million to Accelerate the Rate of Pancreatic Cancer Research
The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced that it has awarded $25 million in new multi-year research grants....
Striving to increase survival rates in pancreatic cancer in the UK
Alex Ford, CEO of Pancreatic Cancer UK, shares with us the aims of the charity and highlights how we can raise awareness of pancreatic cancer. Pancreatic cancer is the ninth most common cancer in th...
Drugs and Medications
La mer the treatment fluid foundation [MAX HUBER RESEARCH LAB INC]
NA
Quik spray [Cinogen Cosmetics Zhaoqing, LTD.]
QuikSpray Advanced Hand Sanitizing Spray
Alco-san instant skin sanitizer [Mid-American Chemical Research Corporation]
ALCO-SAN INSTANT SKIN SANITIZER
Sunscreen [CRC (Cosmoceutical Research Center)]
SUNSCREEN SPF 28/30
VioNexus No Rinse Spray
PubMed Articles
Expression of A20 is reduced in pancreatic cancer tissues.
A20 protein plays essential roles in tumorigenesis, but its value for diagnosis of pancreatic cancer remains unclear. Our aim was to determine whether A20 is a potential biomarker for the diagnosis of...
Understanding pancreatic cancer genomes.
Pancreatic cancer is the fourth leading cause of cancer death in our society, with a mortality that virtually parallels its incidence, a median survival of
New insights into pancreatic cancer-induced paraneoplastic diabetes.
Up to 85% of patients with pancreatic cancer have diabetes or hyperglycaemia, which frequently manifests as early as 2-3 years before a diagnosis of pancreatic cancer. Conversely, patients with new-on...
Pancreatic cancer: Are pancreatic cysts a risk factor for pancreatic cancer?
Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer.
INTRODUCTION: Protein profiles of endoscopically collected pancreatic juice from normal, chronic pancreatitis patients and pancreatic cancer patients were compared to identify diagnostic biomarkers of...
Clinical Trials
Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer
The purpose of this research study is to try to define the highest doses of temsirolimus and gemcitabine that can be used safely in combination to treat advanced pancreatic cancer. Gemcita...
This no treatment research study is being done to find a safe and an appropriate dose of antibody (protein) against tumor cells to best target the cancer in people with pancreatic cancer....
Local Invasion of Pancreatic Cancer
Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microsco...
Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
Pancreatic cancer has traditionally been treated with chemotherapy and radiation therapy with limited results. Preliminary studies of parts of this program in patients with advanced panc...
The goal of this clinical research study is to find the highest safe dose of the drug Bevacizumab that can be given in combination with chemoradiation for the treatment of pancreatic cance...
Companies
The Lustgarten Foundation for Pancreatic Cancer Research
Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit support...
The Lustgarten Foundation, based in Bethpage, New York, is America's largest private foundation dedicated solely to funding pancreatic cancer research. Founded in 1998, the Foundation provides critica...
After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...
Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organizat...
About Pancreatic Cancer Action: 5 year survival rates for pancreatic cancer have not changed in over 40 years and it is our mission to change this by way of increased awareness of pancreatic cancer...
More Information about "The Lustgarten Foundation for Pancreatic Cancer Research" on BioPortfolio
We have published hundreds of The Lustgarten Foundation for Pancreatic Cancer Research news stories on BioPortfolio along with dozens of The Lustgarten Foundation for Pancreatic Cancer Research Clinical Trials and PubMed Articles about The Lustgarten Foundation for Pancreatic Cancer Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Lustgarten Foundation for Pancreatic Cancer Research Companies in our database. You can also find out about relevant The Lustgarten Foundation for Pancreatic Cancer Research Drugs and Medications on this site too.
